The promise of our targets
We approach cancer discovery with an entrepreneurial spirit and choose to pursue targets based on where we believe the science will take us in the next decade, not just a few years from now. Our clinical research and development spans multiple areas, including oncogenic survival mechanisms and immunotherapeutic cancer vaccine optimization.
We invite you to explore our current focus areas below:
HLA patient segmenting, appropriate antigen selection (ex. WT1), and immune stimulation may help address the immunogenecity problem with immunotherapeutic cancer vaccines.Learn more